|
Research Management and Support
|
RMS2010 [E]
|
$345,370,533
|
$185,034
|
N/A
|
National Cancer Institute
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-015
|
$228,267,549
|
$5,355,918
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
Cancer Center Support Grant
|
5P30CA008748-45
|
$13,879,526
|
$138,795
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
$116,418
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S7
|
$8,241,288
|
$164,826
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Core Support Grant
|
3P30CA013148-38S6
|
$5,739,488
|
$229,580
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,160,906
|
$516,091
|
Camphausen, Kevin
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-37
|
$4,795,480
|
$47,955
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Cancer Center Support Grant
|
2P30CA091842-09
|
$4,611,074
|
$92,221
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support (Core) Grant
|
2P30CA014051-39
|
$4,057,188
|
$81,144
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support Grant
|
5P30CA013696-37
|
$4,017,288
|
$40,173
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 010764
|
$2,442,501
|
$610,625
|
Wayne, Alan
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011098
|
$2,375,426
|
$2,375,426
|
Fine, Howard
|
CCR (NCI)
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-12
|
$1,303,718
|
$39,112
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,279,378
|
$191,907
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
|
ZIA SC 004002
|
$1,230,133
|
$184,520
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,188,980
|
$118,898
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,116,032
|
$55,802
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Chaperones and DNA Replication
|
ZIA BC 008710
|
$1,084,385
|
$216,877
|
McKenney, Sue
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$1,028,273
|
$822,618
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Studies of Histone Functions in Chromatin; H2AX and DNA DSBs
|
ZIA BC 006140
|
$954,275
|
$47,714
|
Bonner, William
|
CCR (NCI)
|
|
Relationship between DNA damage detection and signaling
|
ZIA BC 010959
|
$945,121
|
$472,561
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
Search for the Structural Basis of Biomacromolecular Function and Activity
|
ZIA BC 010379
|
$943,339
|
$122,634
|
Wang, Yun-Xing
|
CCR (NCI)
|
|
Clinical Trials with Immunotoxins
|
ZIA BC 010020
|
$937,801
|
$46,890
|
Pastan, Ira
|
CCR (NCI)
|
|
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma
|
ZIA BC 011017
|
$890,223
|
$890,223
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$882,683
|
$132,402
|
Gottesman, Michael
|
CCR (NCI)
|
|
Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other Ge
|
ZIA BC 010801
|
$855,068
|
$641,301
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Center for Applied Preclinical Research (CAPR)
|
ZIC BC 011137
|
$844,143
|
$211,036
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$837,024
|
$83,702
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Mechanism of TNF Signaling and Apoptosis
|
ZIA SC 010376
|
$828,778
|
$580,145
|
Liu, Zheng-Gang
|
CCR (NCI)
|
|
Molecular Basis for the Pathogenesis of Murine Retroviruses
|
ZIA BC 005657
|
$789,756
|
$394,878
|
Ruscetti, Sandra
|
CCR (NCI)
|
|
Determining the Fate of Transmembrane Proteins
|
ZIA BC 009392
|
$784,104
|
$54,887
|
Weissman, Allan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$771,635
|
$77,163
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$768,194
|
$153,639
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Brain Tumor Animal Therapeutics Core
|
ZIC BC 011086
|
$746,562
|
$746,562
|
Fine, Howard
|
CCR (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$737,896
|
$73,790
|
Dean, Michael
|
CCR (NCI)
|
|
Molecular Profiling of Patients Undergoing Radiotherapy
|
ZIA SC 010372
|
$685,515
|
$479,861
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach
|
ZIA BC 011240
|
$675,314
|
$675,314
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Trans-NIH Angiogenesis Core Facility
|
ZIC BC 010964
|
$651,875
|
$130,375
|
Cuttitta, Frank
|
CCR (NCI)
|
|
Cancer Genomics Technology Development
|
ZIA BC 011091
|
$635,323
|
$63,532
|
Meltzer, Paul
|
CCR (NCI)
|
|
Signal Transduction Events and the Regulation of Cell Growth
|
ZIC SC 006743
|
$635,304
|
$31,765
|
Trepel, Jane
|
CCR (NCI)
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIA BC 010539
|
$628,696
|
$565,826
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$627,828
|
$282,523
|
Khan, Javed
|
CCR (NCI)
|
|
Developing new immunotherapies based of CD4+ T cells
|
ZIA BC 011037
|
$585,617
|
$58,562
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Immunobiology of Pediatric Tumors
|
ZIA BC 011073
|
$581,594
|
$116,319
|
Mackall, Crystal
|
CCR (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$570,045
|
$57,005
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$558,016
|
$27,901
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
|
ZIA BC 010839
|
$542,954
|
$542,954
|
Fine, Howard
|
CCR (NCI)
|
|
SCF as a Novel CNS and Glioma-Derived Angiogenic Factor and SC Chemotaxic Factor
|
ZIA BC 011100
|
$542,954
|
$542,954
|
Fine, Howard
|
CCR (NCI)
|
|
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
|
ZIA BC 011101
|
$542,954
|
$542,954
|
Fine, Howard
|
CCR (NCI)
|
Total relevant funding to Nervous System for this search: $36,286,255
|